Technical analysis of NeuroPace, Inc. (NPCE): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories.
Price Performance
| 1 month | -2.56% |
| 3 months | -9.79% |
| Year-to-date | -8.68% |
| 1 year | +42.57% |
| 3 years | +74.50% |
| 5 years | -19.06% |
52-Week Range
| 52-week High | $19.60 |
| 52-week Low | $9.22 |
| Avg Volume (90d) | 183K |
Technical Indicators
| SMA 50 | $14.79 |
| SMA 200 | $15.46 |
| Beta | 1.88 |
| 30-day Volatility (annualised) | 41.4% |
| Price vs SMA 50 | -4.7% |
| Price vs SMA 200 | -8.8% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $9.94 | |
| 2025-11 | $16.36 | +64.6% |
| 2025-12 | $15.44 | -5.6% |
| 2026-01 | $15.13 | -2.0% |
| 2026-02 | $14.58 | -3.6% |
| 2026-03 | $13.15 | -9.8% |
| 2026-04 | $16.86 | +28.2% |
| 2026-05 | $16.54 | -1.9% |
| 2026-06 | $15.89 | -3.9% |
| 2026-07 | $12.89 | -18.9% |
| 2026-08 | $14.65 | +13.7% |
| 2026-09 | $14.10 | -3.8% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-14 | $-2.53 | |
| 2026-09-14 | | $159M |
| 2026-09-14 | $-0.26 | $14M |
| 2026-09-14 | | |
| 2026-09-14 | $0.84 | $26M |
| 2026-09-14 | | |
Price
| Price | $14.10 |
| Market Cap | $481M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 39.18 |
| EV / EBITDA | -43.63 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 5.88 |
| Current Ratio | 4.94 |
| Piotroski F-Score | 5 |
| Altman Z-Score | -2.52 |